We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
(+5.5%)
Cap. Flow
+$84.9M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$66.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$57.7M |
| 3 |
Amazon
AMZN
|
+$56.5M |
| 4 |
Advanced Micro Devices
AMD
|
+$37.5M |
| 5 |
Salesforce
CRM
|
+$35.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$122M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$60.8M |
| 3 |
Applied Materials
AMAT
|
+$43.7M |
| 4 |
Nu Holdings
NU
|
+$35.9M |
| 5 |
Incyte
INCY
|
+$32.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.8% |
| 2 | Healthcare | 28.54% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
CGI
GIB
$15.6B
| $258K | ﹤0.01% |
+2,241
| New | +$245K |
|
627
BCE
BCE
$20.6B
| $252K | ﹤0.01% |
7,236
| – | – |
|
628
American Eagle Outfitters
AEO
$2.92B
| $249K | ﹤0.01% |
11,142
-858
| -7% | -$17.7K |
|
629
ASE Group
ASX
$70.5B
| $218K | ﹤0.01% |
22,315
+2,195
| +11% | +$22.3K |
|
630
Nutanix
NTNX
$16B
| $217K | ﹤0.01% |
+3,655
| New | +$201K |
|
631
Lennox International
LII
$15.4B
| $210K | ﹤0.01% |
+348
| New | +$199K |
|
632
Graco
GGG
$13.2B
| $208K | ﹤0.01% |
+2,382
| New | +$195K |
|
633
Republic Services
RSG
$67.4B
| $207K | ﹤0.01% |
1,032
| – | – |
|
634
Gold Fields
GFI
$28.5B
| $195K | ﹤0.01% |
12,675
| – | – |
|
635
United Microelectronic
UMC
$43.1B
| $192K | ﹤0.01% |
22,764
+2,239
| +11% | +$18.7K |
|
|
VISN
636
Vistance Networks Inc
VISN
$2.63B
| $171K | ﹤0.01% |
+28,054
| New | +$96.2K |
|
637
Lumen
LUMN
$6.33B
| $166K | ﹤0.01% |
+23,408
| New | +$99.9K |
|
638
Nektar Therapeutics
NKTR
$2.34B
| $103K | ﹤0.01% |
5,306
| – | – |
|
639
CEMIG Preferred Shares
CIG
$6.18B
| $68.6K | ﹤0.01% |
33,294
| – | – |
|
640
Ares Management
ARES
$28B
| – | – |
-68,781
| Closed | -$9.17M |
|
641
Arrowhead Research
ARWR
$12.3B
| – | – |
-228,054
| Closed | -$5.93M |
|
642
Brink's
BCO
$4.92B
| – | – |
-20,920
| Closed | -$2.14M |
|
643
Brookfield Renewable
BEPC
$5.84B
| – | – |
-11,551
| Closed | -$327K |
|
644
Blackrock
BLK
$170B
| – | – |
-11,870
| Closed | -$9.35M |
|
|
BPMC
645
DELISTED
Blueprint Medicines
BPMC
| – | – |
-52,066
| Closed | -$5.61M |
|
646
Celldex Therapeutics
CLDX
$2.81B
| – | – |
-317,509
| Closed | -$11.8M |
|
647
Caribou Biosciences
CRBU
$146M
| – | – |
-625,063
| Closed | -$1.03M |
|
648
Crocs
CROX
$6.62B
| – | – |
-17,584
| Closed | -$2.57M |
|
649
CytomX Therapeutics
CTMX
$690M
| – | – |
-210,027
| Closed | -$256K |
|
650
Cousins Properties
CUZ
$5.34B
| – | – |
-86,964
| Closed | -$2.01M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2024 Portfolio in Review
As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
- Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
- Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
- Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
- Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
- Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
- Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.
Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.